Location History:
- Nobeoka, JP (1996 - 2010)
- Tokyo, JP (2012 - 2015)
Company Filing History:
8 out of 510 
3 out of 944 
1 out of 1,297 
Years Active: 1996-2015
Title: Innovations of Yoshihito Yaginuma
Introduction
Yoshihito Yaginuma is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of processes for producing spherical base granules. With a total of 12 patents to his name, Yaginuma's work has advanced the efficiency and effectiveness of drug delivery systems.
Latest Patents
Yaginuma's latest patents include a process for producing spherical base granules that comprise an easily water-soluble drug. This innovative process involves coating pharmaceutically inert spherical core particles with a layer of the drug using a layering liquid. The spherical core particles must have a microcrystalline cellulose content of 30 mass % or greater and a water-absorbing capacity of 0.5 cm/g or greater. Another notable patent focuses on producing spherical base granules containing a hardly water-soluble drug. This method enhances suspension stability by layering spherical core particles with a drug-containing liquid that includes micronized microcrystalline cellulose and an emulsifier.
Career Highlights
Throughout his career, Yaginuma has worked with notable companies such as Asahi Kasei Chemicals Corporation and Asahi Kasei Kabushiki Kaisha. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to various projects that enhance drug formulation techniques.
Collaborations
Yaginuma has collaborated with several professionals in his field, including Nobuyoshi Mochihara and Rika Matsumoto. These collaborations have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking solutions in pharmaceutical technology.
Conclusion
Yoshihito Yaginuma's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a key inventor in drug delivery systems. His work continues to influence the industry and improve patient outcomes.